Literature DB >> 25066399

Meta analysis of XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia.

Zhi-Song Xing1, Guang Zhu2, Yu-Lun Yang1, Guang-Qiang Feng1, Guang-Cheng Ding3.   

Abstract

OBJECTIVE: To assess the relation between XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia.
METHODS: Related studies of XRCC3 Thr241Met polymorphism and lung cancer susceptibility of populations in East Asia were collected through searching the Pubmed, Embase Library, SPRINGER, CNKI and CSSCI.
RESULTS: According to the entry criteria, there were 8 case-control studies in the assessing system and there were 6 321 study cases, including 3 215 patients with lung cancer and 3 106 cases without cancers. Meta analysis results showed the combined OR value of the ratio of genotype Thr/Met+Met/Met and Thr/Thr was 1.03 (95%CI: 0.89-1.20) (P>0.05).
CONCLUSIONS: XRCC3 Thr241Met polymorphism may not related to lung cancer susceptibility of populations in East Asia. Allele 241Met did not increase the risk of lung cancer.
Copyright © 2014 Hainan Medical College. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lung cancer susceptibility; Meta analysis; Populations in East Asia; THr241Met; XRCC3

Mesh:

Substances:

Year:  2014        PMID: 25066399     DOI: 10.1016/S1995-7645(14)60079-1

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  2 in total

1.  Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population.

Authors:  Libin Yang; Yongbo An; Guodong Wang; Tan Lu; Shujuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  XRCC3 Thr241Met Polymorphism is not Associated with Lung Cancer Risk in a Romanian Population.

Authors:  Andreea Catana; Monica Pop; Dragos Horea Marginean; Ioana Cristina Blaga; Mihai Dumitru Porojan; Radu Anghel Popp; Ioan Victor Pop
Journal:  Clujul Med       Date:  2016-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.